by 
The respiratory trainer market comprises various devices that are used to treat illnesses and conditions affecting the respiratory system. Respiratory trainers help patients perform breathing exercises to strengthen their respiratory muscles and lungs. Devices like incentive spirometers, peak flow meters, and portable nebulizers are widely used. Incentive spirometers encourage deep breathing via visual or audio feedback, aiding recovery from surgery. Peak flow meters allow monitoring of lung function over time via measurement of maximum flow achieved during forceful exhalation. Portable nebulizers help deliver medications to the lungs for conditions like asthma in a less invasive way. The growing prevalence of respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma has increased the need for respiratory trainers globally.
The global Respiratory Trainer Market is estimated to be valued at US$ 481.83 Mn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the respiratory trainer market is the development of smart and connected devices. Various players are focusing on integrating smartphone apps and wireless connectivity into respiratory trainers. This allows remote monitoring of patients’ condition and adherence to prescribed treatment plans by physicians. For instance, Respietta by Medical International Research has an accompanying mobile app that can remotely track patients’ activities. Such devices offer added convenience and promote adherence. Furthermore, the growing popularity of online platforms is resulting in increased online sales of respiratory trainers. Major players are focusing on strengthening their e-commerce presence to improve access. This is expected to further aid the market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: The threat to new entrants in the respiratory trainer market is low. Established players have strong brand identity and distribution channels. Significant capital is required to manufacture medical devices.
Bargaining power of buyers: The bargaining power of buyers in the respiratory trainer market is moderate. The market has several buyers like hospitals, clinics, home care settings, and individuals which increases buyer bargaining power. Buyers can choose from various respiratory trainers from different brands.
Bargaining power of suppliers: The bargaining power of suppliers is moderate. Suppliers are dependent on a limited number of manufacturers for business. Changing suppliers involves compliance and testing requirements. Suppliers also have the threat of forward integration by manufacturers.
Threat of new substitutes: The threat of new substitutes in the respiratory trainer market is low. No close substitutes are available for respiratory trainers in delivering respiratory therapies. Technological advancements help address the limitations of existing products.
Competitive rivalry: The competitive rivalry is high. The market is highly fragmented with the presence of several international and regional players. Players compete on product performance, features, brand, price, and quality.
Key Takeaways
The global respiratory trainer market is expected to witness high growth over the forecast period.
Regional analysis: North America is expected to dominate the global respiratory trainer market over the forecast period. This is attributed to increasing cases of respiratory diseases, rising healthcare expenditure, and presence of key market players in the region. Asia Pacific is anticipated to exhibit the fastest growth rate owing to large patient population, improving access to healthcare facilities, and rising awareness regarding respiratory disorders.
Key players: Key players operating in the respiratory trainer market are Medline, Flaem Nuova, Becton Dickinson, Dickinson, Cardinal Health, Nidek Medical India, and Teleflex. Players focus on new product launches, acquisitions, partnerships, and regional expansion to gain market share and cater to the rising demand. In 2022, Medline expanded its portfolio of inhalation therapy products through the acquisition of Integra Apps.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
